313 related articles for article (PubMed ID: 32174913)
21. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
22. Ectopic CD4
Wang K; Hou X; Lu H; Han N; Xie M; Xi A; Xu Z
J Autoimmun; 2024 May; 145():103199. PubMed ID: 38452512
[TBL] [Abstract][Full Text] [Related]
23. The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus.
Tomita M; Khan RL; Blehm BH; Santoro TJ
Med Hypotheses; 2004; 62(3):325-35. PubMed ID: 14975498
[TBL] [Abstract][Full Text] [Related]
24. SLEB3 in systemic lupus erythematosus (SLE) is strongly related to SLE families ascertained through neuropsychiatric manifestations.
Nath SK; Kelly JA; Reid J; Lam T; Gray-McGuire C; Namjou B; Aston CE; Harley JB
Hum Genet; 2002 Jul; 111(1):54-8. PubMed ID: 12136236
[TBL] [Abstract][Full Text] [Related]
25. Anti-IFNAR treatment does not reverse neuropsychiatric disease in MRL/
Huang MW; Stock AD; Mike EV; Herlitz L; Kolbeck R; Putterman C
Lupus; 2019 Nov; 28(13):1510-1523. PubMed ID: 31474191
[TBL] [Abstract][Full Text] [Related]
26. Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice.
Nocito C; Lubinsky C; Hand M; Khan S; Patel T; Seliga A; Winfield M; Zuluaga-Ramirez V; Fernandes N; Shi X; Unterwald EM; Persidsky Y; Sriram U
Front Immunol; 2020; 11():573677. PubMed ID: 33042154
[TBL] [Abstract][Full Text] [Related]
27. Pyruvate kinase isoform M2 impairs cognition in systemic lupus erythematosus by promoting microglial synaptic pruning via the β-catenin signaling pathway.
Lu L; Wang H; Liu X; Tan L; Qiao X; Ni J; Sun Y; Liang J; Hou Y; Dou H
J Neuroinflammation; 2021 Oct; 18(1):229. PubMed ID: 34645459
[TBL] [Abstract][Full Text] [Related]
28. Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: the MRL-lpr mouse strain as a model.
Jeltsch-David H; Muller S
Autoimmun Rev; 2014 Sep; 13(9):963-73. PubMed ID: 25183233
[TBL] [Abstract][Full Text] [Related]
29. Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis.
Zabala A; Salgueiro M; Sáez-Atxukarro O; Ballesteros J; Ruiz-Irastorza G; Segarra R
J Int Neuropsychol Soc; 2018 Jul; 24(6):629-639. PubMed ID: 29553037
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor 4 gene polymorphism 1196 C/T does not influence the risk of neuropsychiatric systemic lupus erythematosus in Polish population--a preliminary report.
Bogaczewicz A; Sobow T; Bogaczewicz J; Kaleta B; Sysa-Jedrzejowska A; Robak E; Lukaszkiewicz J; Dariusz S; Wozniacka A
Lupus; 2013 Dec; 22(14):1504-8. PubMed ID: 24243911
[TBL] [Abstract][Full Text] [Related]
31. A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.
Ercan E; Ingo C; Tritanon O; Magro-Checa C; Smith A; Smith S; Huizinga T; van Buchem MA; Ronen I
Neuroimage Clin; 2015; 8():337-44. PubMed ID: 26106559
[TBL] [Abstract][Full Text] [Related]
32. Advanced MRI techniques: biomarkers in neuropsychiatric lupus.
Sarbu N; Toledano P; Calvo A; Roura E; Sarbu MI; Espinosa G; Lladó X; Cervera R; Bargalló N
Lupus; 2017 Apr; 26(5):510-516. PubMed ID: 28394230
[TBL] [Abstract][Full Text] [Related]
33. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
[TBL] [Abstract][Full Text] [Related]
34. Neuropsychiatric manifestations in a consecutive cohort of systemic lupus erythematosus; a single center study.
Abdul-Sattar AB; Goda T; Negm MG
Int J Rheum Dis; 2013 Dec; 16(6):715-23. PubMed ID: 24382281
[TBL] [Abstract][Full Text] [Related]
35. Circulating brain-reactive autoantibodies and behavioral deficits in the MRL model of CNS lupus.
Williams S; Sakic B; Hoffman SA
J Neuroimmunol; 2010 Jan; 218(1-2):73-82. PubMed ID: 19919882
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic neuropsychiatric effect of stress-induced microglial interleukin 12/23 axis in systemic lupus erythematosus.
Abe N; Tarumi M; Fujieda Y; Takahashi N; Karino K; Uchida M; Kono M; Tanaka Y; Hasebe R; Kato M; Amengual O; Arinuma Y; Oku K; Sato W; Tha KK; Yamasaki M; Watanabe M; Atsumi T; Murakami M
Ann Rheum Dis; 2022 Nov; 81(11):1564-1575. PubMed ID: 35817472
[TBL] [Abstract][Full Text] [Related]
37. Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus.
Chalmers SA; Wen J; Doerner J; Stock A; Cuda CM; Makinde HM; Perlman H; Bosanac T; Webb D; Nabozny G; Fine JS; Klein E; Ramanujam M; Putterman C
Arthritis Res Ther; 2018 Jan; 20(1):10. PubMed ID: 29370834
[TBL] [Abstract][Full Text] [Related]
38. Tertiary lymphoid structures in the choroid plexus in neuropsychiatric lupus.
Stock AD; Der E; Gelb S; Huang M; Weidenheim K; Ben-Zvi A; Putterman C
JCI Insight; 2019 Jun; 4(11):. PubMed ID: 31167973
[TBL] [Abstract][Full Text] [Related]
39. Localization of cerebral functional deficits in patients with non-neuropsychiatric systemic lupus erythematosus.
Lin Y; Zou QH; Wang J; Wang Y; Zhou DQ; Zhang RH; Zhang YW; Lii HT; Fang YF
Hum Brain Mapp; 2011 Nov; 32(11):1847-55. PubMed ID: 21170956
[TBL] [Abstract][Full Text] [Related]
40. Blood-brain barrier disruption and neuroinflammation as pathophysiological mechanisms of the diffuse manifestations of neuropsychiatric systemic lupus erythematosus.
Duarte-Delgado NP; Vásquez G; Ortiz-Reyes BL
Autoimmun Rev; 2019 Apr; 18(4):426-432. PubMed ID: 30763633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
